Eva Maria Rebrova
1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protocol for genomic recombineering in Yersinia ruckeri using CRISPR Cas12a coupled with the lambda Red system
(
- Contribution to journal › Article
- 2023
-
Mark
Contractile Injection Systems and Use Thereof
2023)(
- Patent › Patent
- 2022
-
Mark
Cryo-EM structure of native human thyroglobulin
2022) In Nature Communications(
- Contribution to journal › Article
- 2021
-
Mark
N-Thio-β-lactams targeting L,D-transpeptidase-2, with activity against drug-resistant strains of Mycobacterium tuberculosis
(
- Contribution to journal › Article
- 2018
-
Mark
The structure of the N-terminal module of the cell wall hydrolase RipA and its role in regulating catalytic activity
(
- Contribution to journal › Article
- 2017
-
Mark
Binding and processing of β-lactam antibiotics by the transpeptidase LdtMt2 from Mycobacterium tuberculosis
(
- Contribution to journal › Article
- 2014
-
Mark
CysK2 from Mycobacterium tuberculosis is an O-phospho-L-serine-dependent S-sulfocysteine synthase
(
- Contribution to journal › Article
- 2013
-
Mark
Structure of LdtMt2, an l,d-transpeptidase from Mycobacterium tuberculosis
(
- Contribution to journal › Article